FLAG Therapeutics Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2M
- Investors
-
1
FLAG Therapeutics General Information
Description
Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company focuses on developing new small-molecule therapeutics for difficult-to-treat cancer and its therapies are based on two investigational product platforms that are Anti-angiogenic, Anti-tubulin and the Folate-target Anti-cancer (FTAC) that includes multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types, including brain, lung, ovarian and pancreatic.
Contact Information
Website
www.flagtherapeutics.comCorporate Office
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
Corporate Office
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
FLAG Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Seed Round | 01-Jul-2019 | $2M | Completed | Pre-Clinical Trials | ||
4. Seed Round | 09-Jan-2019 | Completed | Startup | |||
3. Debt - General | 21-Nov-2018 | Completed | Startup | |||
2. Grant | 01-Jan-2017 | $1.5M | $250K | Completed | Startup | |
1. Debt - General | 06-Mar-2015 | $250K | $250K | Completed | Startup |
FLAG Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FLAG Therapeutics Comparisons
Industry
Financing
Details
FLAG Therapeutics Competitors (2)
One of FLAG Therapeutics’s 2 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
Chimerix | Corporate Backed or Acquired | Durham, NC |
FLAG Therapeutics Signals
FLAG Therapeutics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
U.S. Department of Health and Human Services | Government |
FLAG Therapeutics FAQs
-
When was FLAG Therapeutics founded?
FLAG Therapeutics was founded in 2013.
-
Where is FLAG Therapeutics headquartered?
FLAG Therapeutics is headquartered in Raleigh, NC.
-
What is the size of FLAG Therapeutics?
FLAG Therapeutics has 5 total employees.
-
What industry is FLAG Therapeutics in?
FLAG Therapeutics’s primary industry is Drug Discovery.
-
Is FLAG Therapeutics a private or public company?
FLAG Therapeutics is a Private company.
-
What is FLAG Therapeutics’s current revenue?
The current revenue for FLAG Therapeutics is
. -
How much funding has FLAG Therapeutics raised over time?
FLAG Therapeutics has raised $4.05M.
-
Who are FLAG Therapeutics’s investors?
U.S. Department of Health and Human Services has invested in FLAG Therapeutics.
-
Who are FLAG Therapeutics’s competitors?
Sutro Biopharma and Chimerix are competitors of FLAG Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »